speb/financial-data huggingface dataset:
CREX cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -2000000.00
CREX income_statement (annual, 2023-12-31) — Special Income Charges: -1419000.00
CREX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 563000.00
CREX balance_sheet (annual, 2023-12-31) — Stockholders Equity: 28831000.00
CREX balance_sheet (annual, 2023-12-31) — Tangible Book Value: -21684000.00
CREX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -297990.00
CREX income_statement (annual, 2023-12-31) — Tax Provision: 83000.00
CREX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
CREX balance_sheet (annual, 2023-12-31) — Total Assets: 70777000.00
CREX balance_sheet (annual, 2023-12-31) — Total Capitalization: 38660000.00
CREX balance_sheet (annual, 2023-12-31) — Total Debt: 14560000.00
CREX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 28831000.00
CREX income_statement (annual, 2023-12-31) — Total Expenses: 43820000.00
CREX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 41946000.00
CREX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 52167000.00
CREX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 21749000.00
CREX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 1346000.00
CREX income_statement (annual, 2023-12-31) — Total Unusual Items: -1419000.00
CREX income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1419000.00
CREX balance_sheet (annual, 2023-12-31) — Work In Process: 504000.00
CREX balance_sheet (annual, 2023-12-31) — Working Capital: -1587000.00
CREX cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 56000.00
CREX cash_flow (quarterly, 2024-09-30) — Operating Gains Losses: 0.00
CREX balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 743000.00
CREX balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 10794000.00
CREX balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 309000.00
CREX income_statement (quarterly, 2024-09-30) — Write Off: 0.00
CREX income_statement (annual, 2024-12-31) — +Operating Expense: 23073000.00
CREX income_statement (annual, 2024-12-31) — +Total Revenue: 50854000.00
CREX balance_sheet (annual, 2024-12-31) — Accounts Payable: 6354000.00
CREX balance_sheet (annual, 2024-12-31) — Accounts Receivable: 10605000.00
CREX balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -364000.00
CREX balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -364000.00
CREX balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 82210000.00
CREX balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -708000.00
CREX cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 13000.00
CREX cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: -173000.00
CREX income_statement (annual, 2024-12-31) — Basic Average Shares: 10440000.00
CREX income_statement (annual, 2024-12-31) — Basic EPS: -0.34
CREX cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2910000.00
CREX cash_flow (annual, 2024-12-31) — Capital Expenditure: -2801000.00
CREX cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -2790000.00
CREX balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 922000.00
CREX balance_sheet (annual, 2024-12-31) — Capital Stock: 104000.00
CREX balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1037000.00
CREX balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1037000.00
CREX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -2453000.00
CREX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -2801000.00
CREX cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 3381000.00
CREX cash_flow (annual, 2024-12-31) — Change In Account Payable: -1388000.00
CREX cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -395000.00
CREX cash_flow (annual, 2024-12-31) — Change In Inventory: 615000.00
CREX cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 43000.00
CREX cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -270000.00
CREX cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -1047000.00
CREX cash_flow (annual, 2024-12-31) — Change In Payable: -1388000.00
CREX cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -1783000.00
CREX cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -194000.00
CREX cash_flow (annual, 2024-12-31) — Change In Receivables: 1850000.00
CREX cash_flow (annual, 2024-12-31) — Change In Working Capital: -786000.00
CREX cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 1850000.00
CREX cash_flow (annual, 2024-12-31) — Changes In Cash: -1873000.00
CREX balance_sheet (annual, 2024-12-31) — Common Stock: 104000.00
CREX balance_sheet (annual, 2024-12-31) — Common Stock Equity: 25460000.00
CREX cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
CREX cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CREX income_statement (annual, 2024-12-31) — Cost Of Revenue: 26843000.00
CREX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 952000.00
CREX balance_sheet (annual, 2024-12-31) — Current Assets: 14496000.00
CREX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 512000.00
CREX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 512000.00
CREX balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 3318000.00
CREX balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 3318000.00
CREX balance_sheet (annual, 2024-12-31) — Current Liabilities: 26163000.00
CREX cash_flow (annual, 2024-12-31) — Deferred Income Tax: 61000.00
CREX cash_flow (annual, 2024-12-31) — Deferred Tax: 61000.00
CREX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 4078000.00
CREX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 4078000.00
CREX income_statement (annual, 2024-12-31) — Diluted Average Shares: 10440000.00
CREX income_statement (annual, 2024-12-31) — Diluted EPS: -0.34
CREX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -3508000.00
CREX income_statement (annual, 2024-12-31) — EBIT: -1627000.00
CREX income_statement (annual, 2024-12-31) — EBITDA: 2451000.00
CREX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 0.00
CREX cash_flow (annual, 2024-12-31) — End Cash Position: 1037000.00
CREX cash_flow (annual, 2024-12-31) — Financing Cash Flow: -2453000.00
CREX cash_flow (annual, 2024-12-31) — Free Cash Flow: 580000.00
CREX balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CREX balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CREX income_statement (annual, 2024-12-31) — General And Administrative Expense: 17058000.00
CREX balance_sheet (annual, 2024-12-31) — Goodwill: 26453000.00
CREX balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 49294000.00
CREX balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 11313000.00
CREX balance_sheet (annual, 2024-12-31) — Gross PPE: 1472000.00
CREX income_statement (annual, 2024-12-31) — Gross Profit: 24011000.00
CREX income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CREX cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 52000.00
CREX income_statement (annual, 2024-12-31) — Interest Expense: 1775000.00
CREX income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 1775000.00
CREX cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1195000.00
CREX balance_sheet (annual, 2024-12-31) — Interest Payable: 96000.00
CREX balance_sheet (quarterly, 2024-12-31) — Interest Payable: 96000.00
CREX balance_sheet (annual, 2024-12-31) — Inventory: 1995000.00
CREX balance_sheet (annual, 2024-12-31) — Invested Capital: 38504000.00
CREX cash_flow (annual, 2024-12-31) — Investing Cash Flow: -2801000.00
CREX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
CREX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CREX cash_flow (annual, 2024-12-31) — Issuance Of Debt: 31459000.00
CREX balance_sheet (annual, 2024-12-31) — Leases: 141000.00
CREX balance_sheet (quarterly, 2024-12-31) — Leases: 141000.00
CREX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 410000.00
CREX balance_sheet (annual, 2024-12-31) — Long Term Debt: 13044000.00
CREX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 13454000.00
CREX cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 31459000.00
CREX cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -33606000.00
CREX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 189000.00
CREX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 189000.00
CREX cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CREX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CREX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CREX balance_sheet (annual, 2024-12-31) — Net Debt: 12007000.00
CREX income_statement (annual, 2024-12-31) — Net Income: -3508000.00
CREX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -3508000.00
CREX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -3508000.00
CREX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3508000.00
CREX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3508000.00
CREX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -3508000.00
CREX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -3508000.00
CREX income_statement (annual, 2024-12-31) — Net Interest Income: -1775000.00
CREX cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -2147000.00
CREX cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -2147000.00
CREX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -1775000.00
CREX cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -306000.00
CREX cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -17000.00
CREX balance_sheet (annual, 2024-12-31) — Net PPE: 1108000.00
CREX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -11000.00
CREX cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
CREX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -23834000.00
CREX balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 133000.00
CREX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 133000.00
CREX balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 133000.00
CREX balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 133000.00
CREX income_statement (annual, 2024-12-31) — Normalized EBITDA: 5118000.00
CREX income_statement (annual, 2024-12-31) — Normalized Income: -1401070.00
CREX cash_flow (annual, 2024-12-31) — Operating Cash Flow: 3381000.00
CREX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1059000.00
CREX cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 0.00
CREX income_statement (annual, 2024-12-31) — Operating Income: 938000.00
CREX income_statement (annual, 2024-12-31) — Operating Revenue: 50854000.00
CREX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 10446659.00
CREX balance_sheet (annual, 2024-12-31) — Other Current Assets: 859000.00
CREX balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 859000.00
CREX balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 12815000.00
CREX balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 12815000.00
CREX income_statement (annual, 2024-12-31) — Other Gand A: 17058000.00
CREX income_statement (annual, 2024-12-31) — Other Income Expense: -2565000.00
CREX balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 22841000.00
CREX cash_flow (annual, 2024-12-31) — Other Non Cash Items: 2494000.00
CREX balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 312000.00
CREX balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 201000.00
CREX balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 201000.00
CREX income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 102000.00
CREX balance_sheet (annual, 2024-12-31) — Other Properties: 1142000.00
CREX balance_sheet (annual, 2024-12-31) — Other Receivables: 196000.00
CREX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 196000.00
CREX income_statement (annual, 2024-12-31) — Other Special Charges: 1059000.00
CREX income_statement (quarterly, 2024-12-31) — Other Special Charges: 0.00
CREX balance_sheet (annual, 2024-12-31) — Payables: 7743000.00
CREX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 8695000.00
CREX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 823000.00
CREX balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 823000.00
CREX cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
CREX cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
CREX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 663000.00
CREX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 663000.00
CREX income_statement (annual, 2024-12-31) — Pretax Income: -3402000.00
CREX balance_sheet (annual, 2024-12-31) — Properties: 0.00
CREX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CREX cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: -43000.00
CREX cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CREX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -11000.00
CREX balance_sheet (annual, 2024-12-31) — Raw Materials: 1465000.00
CREX balance_sheet (annual, 2024-12-31) — Receivables: 10801000.00
CREX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 26843000.00
CREX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 4078000.00
CREX cash_flow (annual, 2024-12-31) — Repayment Of Debt: -33606000.00
CREX cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CREX income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 1608000.00
CREX balance_sheet (annual, 2024-12-31) — Retained Earnings: -56854000.00
CREX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 6015000.00
CREX income_statement (annual, 2024-12-31) — Selling General And Administration: 23073000.00
CREX balance_sheet (annual, 2024-12-31) — Share Issued: 10446659.00
CREX income_statement (annual, 2024-12-31) — Special Income Charges: -2667000.00
CREX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 13000.00
CREX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 25460000.00
CREX balance_sheet (annual, 2024-12-31) — Tangible Book Value: -23834000.00
CREX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -560070.00
CREX income_statement (annual, 2024-12-31) — Tax Provision: 106000.00
CREX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CREX balance_sheet (annual, 2024-12-31) — Taxes Receivable: 0.00
CREX balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 0.00
CREX balance_sheet (annual, 2024-12-31) — Total Assets: 65210000.00
CREX balance_sheet (annual, 2024-12-31) — Total Capitalization: 38504000.00
CREX balance_sheet (annual, 2024-12-31) — Total Debt: 13966000.00
CREX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 25460000.00
CREX income_statement (annual, 2024-12-31) — Total Expenses: 49916000.00
CREX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 39750000.00
CREX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 50714000.00
CREX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 13587000.00
CREX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 938000.00
CREX balance_sheet (annual, 2024-12-31) — Total Tax Payable: 1389000.00
CREX balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 1389000.00
CREX income_statement (annual, 2024-12-31) — Total Unusual Items: -2667000.00
CREX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -2667000.00
CREX balance_sheet (annual, 2024-12-31) — Work In Process: 530000.00
CREX balance_sheet (annual, 2024-12-31) — Working Capital: -11667000.00
CREX income_statement (quarterly, 2025-03-31) — +Operating Expense: 5175000.00
CREX income_statement (quarterly, 2025-03-31) — +Total Revenue: 9734000.00
CREX balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4658000.00
CREX balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 12983000.00
CREX balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 83252000.00
CREX balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -699000.00
CREX cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 1136000.00
CREX cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 1136000.00
CREX income_statement (quarterly, 2025-03-31) — Basic Average Shares: 10447000.00
CREX income_statement (quarterly, 2025-03-31) — Basic EPS: 0.32
CREX cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 1037000.00
CREX cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -621000.00
CREX cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -613000.00
CREX balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 699000.00
CREX balance_sheet (quarterly, 2025-03-31) — Capital Stock: 104000.00
CREX balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1149000.00
CREX balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1149000.00
CREX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 3182000.00
CREX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -621000.00
CREX cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2449000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1744000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -431000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Inventory: 189000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -47000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -120000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 2212000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Payable: -1744000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2175000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -100000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2378000.00
CREX cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2419000.00
CREX cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -2378000.00
CREX cash_flow (quarterly, 2025-03-31) — Changes In Cash: 112000.00
CREX balance_sheet (quarterly, 2025-03-31) — Common Stock: 104000.00
CREX balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 29870000.00
CREX income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5281000.00
CREX balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2767000.00
CREX balance_sheet (quarterly, 2025-03-31) — Current Assets: 16879000.00
CREX balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 404000.00
CREX balance_sheet (quarterly, 2025-03-31) — Current Debt: 387000.00
CREX balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 791000.00
CREX balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 5530000.00
CREX balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 5530000.00
CREX balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 13746000.00
CREX cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 39000.00
CREX cash_flow (quarterly, 2025-03-31) — Deferred Tax: 39000.00
CREX cash_flow (quarterly, 2025-03-31) — Depreciation: 51000.00
CREX cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1187000.00
CREX cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1187000.00
CREX income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 10447000.00
CREX income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.32
CREX income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 3368000.00
CREX income_statement (quarterly, 2025-03-31) — EBIT: 3788000.00
CREX income_statement (quarterly, 2025-03-31) — EBITDA: 4975000.00
CREX cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
CREX cash_flow (quarterly, 2025-03-31) — End Cash Position: 1149000.00
CREX cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 3182000.00
CREX cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3070000.00
CREX income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3928000.00
CREX balance_sheet (quarterly, 2025-03-31) — Goodwill: 26453000.00
CREX balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 48762000.00
CREX balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 13682000.00
CREX balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1017000.00
CREX income_statement (quarterly, 2025-03-31) — Gross Profit: 4453000.00
CREX cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 1000.00
CREX income_statement (quarterly, 2025-03-31) — Interest Expense: 321000.00
CREX income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 321000.00
CREX cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 270000.00
CREX balance_sheet (quarterly, 2025-03-31) — Inventory: 1788000.00
CREX balance_sheet (quarterly, 2025-03-31) — Invested Capital: 53108000.00
CREX cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -621000.00
CREX cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 12111000.00
CREX balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 295000.00
CREX balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 22851000.00
CREX balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 23146000.00
CREX cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 12111000.00
CREX cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -5929000.00
CREX balance_sheet (quarterly, 2025-03-31) — Net Debt: 22089000.00
CREX income_statement (quarterly, 2025-03-31) — Net Income: 3368000.00
CREX income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 3368000.00
CREX income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3368000.00
CREX income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 3368000.00
CREX income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3368000.00
CREX cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 3368000.00
CREX income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 3368000.00
CREX income_statement (quarterly, 2025-03-31) — Net Interest Income: -321000.00
CREX cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 6182000.00
CREX cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 6182000.00
CREX income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -321000.00
CREX cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -3000000.00
CREX balance_sheet (quarterly, 2025-03-31) — Net PPE: 1017000.00
CREX cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -8000.00
CREX balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -18892000.00
CREX income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 200000.00
CREX income_statement (quarterly, 2025-03-31) — Normalized Income: -1270650.13
CREX cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2449000.00
CREX income_statement (quarterly, 2025-03-31) — Operating Income: -722000.00
CREX income_statement (quarterly, 2025-03-31) — Operating Revenue: 9734000.00
CREX balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 10446659.00
CREX balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 959000.00
CREX balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 387000.00
CREX income_statement (quarterly, 2025-03-31) — Other Gand A: 3928000.00
CREX income_statement (quarterly, 2025-03-31) — Other Income Expense: 4510000.00
CREX balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 22309000.00
CREX cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -4644000.00
CREX balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 333000.00
CREX balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 229000.00
CREX income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -265000.00
CREX balance_sheet (quarterly, 2025-03-31) — Other Properties: 1017000.00
CREX balance_sheet (quarterly, 2025-03-31) — Payables: 4658000.00
CREX balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 7425000.00
CREX income_statement (quarterly, 2025-03-31) — Pretax Income: 3467000.00
CREX cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CREX cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 18000.00
CREX cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -8000.00
CREX balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1252000.00
CREX balance_sheet (quarterly, 2025-03-31) — Receivables: 12983000.00
CREX income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5281000.00
CREX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1187000.00
CREX cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -5929000.00
CREX income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: -4775000.00
CREX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -53486000.00
CREX income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 1247000.00
CREX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 5175000.00
CREX balance_sheet (quarterly, 2025-03-31) — Share Issued: 10446659.00
CREX income_statement (quarterly, 2025-03-31) — Special Income Charges: 4775000.00
CREX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2000.00
CREX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 29870000.00
CREX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -18892000.00
CREX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 136349.87
CREX income_statement (quarterly, 2025-03-31) — Tax Provision: 99000.00
CREX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.03
CREX balance_sheet (quarterly, 2025-03-31) — Total Assets: 66991000.00
CREX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 52721000.00
CREX balance_sheet (quarterly, 2025-03-31) — Total Debt: 23937000.00
CREX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 29870000.00
CREX income_statement (quarterly, 2025-03-31) — Total Expenses: 10456000.00
CREX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 37121000.00
CREX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 50112000.00
CREX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 23375000.00
CREX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -722000.00
CREX income_statement (quarterly, 2025-03-31) — Total Unusual Items: 4775000.00
CREX income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 4775000.00
CREX balance_sheet (quarterly, 2025-03-31) — Work In Process: 536000.00
CREX balance_sheet (quarterly, 2025-03-31) — Working Capital: 3133000.00
CREX income_statement (quarterly, 2025-06-30) — +Operating Expense: 6348000.00
CREX income_statement (quarterly, 2025-06-30) — +Total Revenue: 13030000.00
CREX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 6169000.00
CREX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 10569000.00
CREX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 84641000.00
CREX balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -630000.00
CREX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 10496000.00
CREX income_statement (quarterly, 2025-06-30) — Basic EPS: -0.17
CREX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 1149000.00
CREX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -643000.00
CREX cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -542000.00
CREX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1911000.00
CREX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 105000.00
CREX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 569000.00
CREX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 569000.00
CREX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3159000.00
CREX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -643000.00
CREX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 3222000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1537000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -337000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Inventory: 737000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -2062000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Payable: 1537000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 1200000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 138000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 2357000.00
CREX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2537000.00
CREX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 2357000.00
CREX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -580000.00
CREX balance_sheet (quarterly, 2025-06-30) — Common Stock: 105000.00
CREX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 29443000.00
CREX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8013000.00
CREX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 2368000.00
CREX balance_sheet (quarterly, 2025-06-30) — Current Assets: 13114000.00
CREX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 420000.00
CREX balance_sheet (quarterly, 2025-06-30) — Current Debt: 591000.00
CREX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1011000.00
CREX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 3482000.00
CREX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 3482000.00
CREX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 13030000.00
CREX cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -30000.00
CREX cash_flow (quarterly, 2025-06-30) — Deferred Tax: -30000.00
CREX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1217000.00
CREX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1217000.00
CREX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 10496000.00
CREX income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.17
CREX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1817000.00
CREX income_statement (quarterly, 2025-06-30) — EBIT: -1330000.00
CREX income_statement (quarterly, 2025-06-30) — EBITDA: -113000.00
CREX cash_flow (quarterly, 2025-06-30) — End Cash Position: 569000.00
CREX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3159000.00
CREX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2579000.00
CREX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 5192000.00
CREX balance_sheet (quarterly, 2025-06-30) — Goodwill: 26453000.00
CREX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 48145000.00
CREX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 11199000.00
CREX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2143000.00
CREX income_statement (quarterly, 2025-06-30) — Gross Profit: 5017000.00
CREX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 52000.00
CREX income_statement (quarterly, 2025-06-30) — Interest Expense: 513000.00
CREX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 513000.00
CREX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 478000.00
CREX balance_sheet (quarterly, 2025-06-30) — Inventory: 1055000.00
CREX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 49536000.00
CREX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -643000.00
CREX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 6223000.00
CREX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1491000.00
CREX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 19502000.00
CREX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 20993000.00
CREX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 6223000.00
CREX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -9382000.00
CREX balance_sheet (quarterly, 2025-06-30) — Net Debt: 19524000.00
CREX income_statement (quarterly, 2025-06-30) — Net Income: -1817000.00
CREX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1817000.00
CREX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1817000.00
CREX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1817000.00
CREX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1817000.00
CREX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -1817000.00
CREX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1817000.00
CREX income_statement (quarterly, 2025-06-30) — Net Interest Income: -513000.00
CREX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -3159000.00
CREX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -3159000.00
CREX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -513000.00
CREX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
CREX balance_sheet (quarterly, 2025-06-30) — Net PPE: 2143000.00
CREX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -101000.00
CREX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -18702000.00
CREX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -113000.00
CREX income_statement (quarterly, 2025-06-30) — Normalized Income: -1817000.00
CREX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 3222000.00
CREX income_statement (quarterly, 2025-06-30) — Operating Income: -1331000.00
CREX income_statement (quarterly, 2025-06-30) — Operating Revenue: 13030000.00
CREX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 10518932.00
CREX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 921000.00
CREX balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 591000.00
CREX income_statement (quarterly, 2025-06-30) — Other Gand A: 5192000.00
CREX income_statement (quarterly, 2025-06-30) — Other Income Expense: 1000.00
CREX balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 21692000.00
CREX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -80000.00
CREX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 251000.00
CREX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 187000.00
CREX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1000.00
CREX balance_sheet (quarterly, 2025-06-30) — Other Properties: 2143000.00
CREX balance_sheet (quarterly, 2025-06-30) — Payables: 6169000.00
CREX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 8537000.00
CREX income_statement (quarterly, 2025-06-30) — Pretax Income: -1843000.00
CREX cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: -4000.00
CREX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -101000.00
CREX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 667000.00
CREX balance_sheet (quarterly, 2025-06-30) — Receivables: 10569000.00
CREX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8013000.00
CREX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1217000.00
CREX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -9382000.00
CREX income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
CREX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -55303000.00
CREX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1156000.00
CREX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6348000.00
CREX balance_sheet (quarterly, 2025-06-30) — Share Issued: 10518932.00
CREX income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CREX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1342000.00
CREX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 29443000.00
CREX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -18702000.00
CREX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CREX income_statement (quarterly, 2025-06-30) — Tax Provision: -26000.00
CREX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.01
CREX balance_sheet (quarterly, 2025-06-30) — Total Assets: 63653000.00
CREX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 48945000.00
CREX balance_sheet (quarterly, 2025-06-30) — Total Debt: 22004000.00
CREX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 29443000.00
CREX income_statement (quarterly, 2025-06-30) — Total Expenses: 14361000.00
CREX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 34210000.00
CREX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 50539000.00
CREX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 21180000.00
CREX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1331000.00
CREX income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CREX income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CREX balance_sheet (quarterly, 2025-06-30) — Work In Process: 388000.00
CREX balance_sheet (quarterly, 2025-06-30) — Working Capital: 84000.00
CREX income_statement (quarterly, 2025-09-30) — +Operating Expense: 6335000.00
CREX income_statement (quarterly, 2025-09-30) — +Total Revenue: 10547000.00
CREX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 8705000.00
CREX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 11084000.00
CREX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 84949000.00
CREX balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -709000.00
CREX cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 5856000.00
CREX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 10519000.00
CREX income_statement (quarterly, 2025-09-30) — Basic EPS: -0.75
CREX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 569000.00
CREX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -709000.00
CREX cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -608000.00
CREX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1804000.00
CREX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 105000.00
CREX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 314000.00
CREX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 314000.00
CREX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2061000.00
CREX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -709000.00
CREX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1607000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 2591000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 166000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Inventory: -3245000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 344000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Payable: 2591000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 2757000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -369000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Receivables: -659000.00
CREX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1172000.00
CREX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -659000.00
CREX cash_flow (quarterly, 2025-09-30) — Changes In Cash: -255000.00
CREX balance_sheet (quarterly, 2025-09-30) — Common Stock: 105000.00
CREX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 21889000.00
CREX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 5770000.00
CREX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2552000.00
CREX balance_sheet (quarterly, 2025-09-30) — Current Assets: 16993000.00
CREX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 420000.00
CREX balance_sheet (quarterly, 2025-09-30) — Current Debt: 802000.00
CREX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1222000.00
CREX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 3988000.00
CREX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 3988000.00
CREX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 16467000.00
CREX cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -10000.00
CREX cash_flow (quarterly, 2025-09-30) — Deferred Tax: -10000.00
CREX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1225000.00
CREX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1225000.00
CREX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 10519000.00
CREX income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.75
CREX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -7862000.00
CREX income_statement (quarterly, 2025-09-30) — EBIT: -7414000.00
CREX income_statement (quarterly, 2025-09-30) — EBITDA: -6189000.00
CREX cash_flow (quarterly, 2025-09-30) — End Cash Position: 314000.00
CREX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2061000.00
CREX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2316000.00
CREX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4963000.00
CREX balance_sheet (quarterly, 2025-09-30) — Goodwill: 26453000.00
CREX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 41836000.00
CREX balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 11793000.00
CREX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2064000.00
CREX income_statement (quarterly, 2025-09-30) — Gross Profit: 4777000.00
CREX income_statement (quarterly, 2025-09-30) — Interest Expense: 530000.00
CREX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 530000.00
CREX balance_sheet (quarterly, 2025-09-30) — Inventory: 4305000.00
CREX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 44052000.00
CREX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -709000.00
CREX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 9881000.00
CREX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1384000.00
CREX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 21361000.00
CREX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 22745000.00
CREX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 9881000.00
CREX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -7820000.00
CREX balance_sheet (quarterly, 2025-09-30) — Net Debt: 21849000.00
CREX income_statement (quarterly, 2025-09-30) — Net Income: -7862000.00
CREX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -7862000.00
CREX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -7862000.00
CREX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -7862000.00
CREX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -7862000.00
CREX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -7862000.00
CREX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -7862000.00
CREX income_statement (quarterly, 2025-09-30) — Net Interest Income: -530000.00
CREX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 2061000.00
CREX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 2061000.00
CREX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -530000.00
CREX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
CREX balance_sheet (quarterly, 2025-09-30) — Net PPE: 2064000.00
CREX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -101000.00
CREX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -19947000.00
CREX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -477000.00
CREX income_statement (quarterly, 2025-09-30) — Normalized Income: -2208960.73
CREX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1607000.00
CREX income_statement (quarterly, 2025-09-30) — Operating Income: -1558000.00
CREX income_statement (quarterly, 2025-09-30) — Operating Revenue: 10547000.00
CREX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 10518932.00
CREX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1290000.00
CREX balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 802000.00
CREX income_statement (quarterly, 2025-09-30) — Other Gand A: 4963000.00
CREX income_statement (quarterly, 2025-09-30) — Other Income Expense: -5856000.00
CREX balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 15383000.00
CREX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 26000.00
CREX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 373000.00
CREX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 165000.00
CREX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -144000.00
CREX balance_sheet (quarterly, 2025-09-30) — Other Properties: 2064000.00
CREX balance_sheet (quarterly, 2025-09-30) — Payables: 8705000.00
CREX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 11257000.00
CREX income_statement (quarterly, 2025-09-30) — Pretax Income: -7944000.00
CREX cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -5000.00
CREX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -101000.00
CREX balance_sheet (quarterly, 2025-09-30) — Raw Materials: 3905000.00
CREX balance_sheet (quarterly, 2025-09-30) — Receivables: 11084000.00
CREX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 5770000.00
CREX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1225000.00
CREX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -7820000.00
CREX income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
CREX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -63165000.00